Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Free Report) in a report published on Monday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Price Performance Shares of Ampio Pharmaceuticals stock opened at $0.22 on Monday. The business has a fifty day simple moving average of […]

Related Keywords

Englewood ,Colorado ,United States , ,Institutional Investors Weigh In On Ampio Pharmaceuticals ,Millennium Management ,Ampio Pharmaceuticals Inc ,Ampio Pharmaceuticals ,Pricet Rowe Associates Inc ,News Ratings For Ampio Pharmaceuticals Daily ,Ampio Pharmaceuticals Price Performance ,Vanguard Group Inc ,Free Report ,Sigma Advisers ,Ampio Pharmaceuticals Daily ,